OraSure Technologies Covid Test Selected by HHS for School Programs

By Chris Wack

OraSure Technologies Inc. said Wednesday that its InteliSwab Covid-19 rapid test has been selected by the U.S. Department of Health and Human Services to be distributed to schools nationwide.

The company said the HHS program provides school districts with at-home Covid-19 test kits to be sent home with students, teachers and staff to help keep the nation's schools safe as the pandemic continues. Tests provided under this program will be funded as part of OraSure's procurement contract from the Defense Logistics Agency.

OraSure said the overall accuracy of the InteliSwab test including a pediatric population is 93%, demonstrating comparable accuracy to that in adults.

InteliSwab users swab their lower nostrils with the test stick, swirl it in a pre-measured solution, and see their result on the test stick in 30 minutes.

OraSure shares were up 14% to $5.16 in premarket trading.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

May 25, 2022 07:36 ET (11:36 GMT)

OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Mar 2024 to Apr 2024